You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Keratoacanthoma

Showing 1 - 25 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)

Not yet recruiting
  • BCC - Basal Cell Carcinoma
  • +6 more
  • Marseille, France
    Hôpital de la Timone
Jun 22, 2022

Squamous Cell Carcinoma, Skin Cancer, Keratoacanthoma Trial in Scottsdale, Tucson (Injection of TVEC into target lesions - week

Recruiting
  • Squamous Cell Carcinoma
  • +5 more
  • Injection of TVEC into target lesions - week 1-2
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Apr 6, 2022

Keloid, Alopecia Areata, Acne Trial in Nashville (Corticosteroid with lidocaine, Corticosteroid with normal saline)

Completed
Has Results
  • Keloid
  • +14 more
  • Corticosteroid with lidocaine
  • Corticosteroid with normal saline
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Feb 18, 2021

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Non-melanoma Skin Cancers Trial in Zagazig (Methotrexate)

Completed
  • Non-melanoma Skin Cancers
  • Zagazig, Sharkia, Egypt
    Zagazig university
Apr 6, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Prospective, Non-interventional, Post-authorization Safety Study

Active, not recruiting
  • Thyroid Carcinoma
  • Sorafenib (Nexavar, BAY43-9006)
  • Multiple Locations, Japan
    (unnamed)
Aug 18, 2022

Melanoma Trial in United States (LGX818)

Completed
Has Results
  • Melanoma
  • Basking Ridge, New Jersey
  • +4 more
Jun 7, 2021

Postmenopausal Osteoporosis Trial in Worldwide (Romozosumab, Teriparatide)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Gainesville, Georgia
  • +49 more
Nov 4, 2022

Anemia; Non-dialysis Dependent Chronic Kidney Disease Trial in Japan (MT-6548, Darbepoetin alfa)

Completed
Has Results
  • Anemia; Non-dialysis Dependent Chronic Kidney Disease
  • Aichi, Japan
  • +30 more
Aug 2, 2021

Melanoma Trial (pembrolizumab, )

Active, not recruiting
Has Results
  • Melanoma
  • pembrolizumab
  • placebo
  • (no location specified)
Aug 18, 2022

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +209 more
Nov 14, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +49 more
Apr 1, 2022

Parapsoriasis Trial in United States (Apremilast, Placebo, Placebo-Apremilast)

Completed
Has Results
  • Parapsoriasis
  • Birmingham, Alabama
  • +25 more
Mar 3, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Melanoma Trial in Worldwide (Encorafenib and Binimetinib, Placebo to match Encorafenib ; Placebo to match Binimetinib)

Recruiting
  • Melanoma
  • Encorafenib and Binimetinib
  • Placebo to match Encorafenib ; Placebo to match Binimetinib
  • Caba, Buenos Aires, Argentina
  • +169 more
Jul 5, 2022

Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab)

Completed
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • pembrolizumab
  • (no location specified)
Jun 23, 2022

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Anchorage, Alaska
  • +161 more
Oct 26, 2022

B-cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Placebo)

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +240 more
Nov 24, 2021

Chin Retrusion Trial in United States (JUVÉDERM VOLUMA® XC)

Completed
Has Results
  • Chin Retrusion
  • JUVÉDERM VOLUMA® XC
  • San Diego, California
  • +13 more
Jul 10, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Phoenix, Arizona
  • +134 more
Dec 7, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Homewood, Alabama
  • +143 more
Dec 7, 2021

Actinic Keratosis Trial in United States (Imiquimod Cream, 3.75%, Zyclara®, Vehicle of Test Product)

Completed
Has Results
  • Actinic Keratosis
  • Imiquimod Cream, 3.75%
  • +2 more
  • Tucson, Arizona
  • +22 more
Nov 6, 2020